TABLE 3.
Prevalence and Adherence to Medications Among HIV-Infected and Syphilis-Infected Women by Province, SA, January 2005 to June 2006
| Overall (N = 2379) | GP (n = 1167) | NC (n = 1212) | ||||
|---|---|---|---|---|---|---|
| Characteristic | n | % | n | % | n | % |
| HIV test uptake in ANC and labor/delivery* | 1747 | 74.2 | 873 | 75.5 | 874 | 73.0 |
| HIV prevalence among women tested | 243 | 13.9 | 112 | 12.8 | 131 | 15.0 |
| Syphilis test uptake in ANC and labor/delivery | 2008 | 84.4 | 982 | 82.0 | 1026 | 84.7 |
| Syphilis prevalence among women tested† | 99 | 4.9 | 39 | 4.0 | 60 | 5.8 |
| HIV prophylaxis | ||||||
| Overall ARV prophylaxis uptake before delivery | ||||||
| Yes | 104 | 42.8 | 40 | 35.7 | 64 | 48.9 |
| No | 139 | 57.2 | 72 | 64.3 | 67 | 51.1 |
| SdNVP provided to HIV+ women during ANC | ||||||
| Yes | 103 | 47.5 | 26 | 26.0 | 77 | 65.8 |
| No | 114 | 52.5 | 74 | 74.0 | 40 | 34.2 |
| Adherence to sdNVP at labor‡ | ||||||
| Yes | 53 | 51.5 | 9 | 34.6 | 44 | 57.1 |
| No | 50 | 48.5 | 17 | 65.4 | 33 | 42.9 |
| Not documented | ||||||
| Syphilis treatment | ||||||
| Documented receipt of at least 1 dose of penicillin | ||||||
| Yes | 72 | 73.5 | 21 | 56.8 | 51 | 83.6 |
| No | 26 | 26.5 | 16 | 43.2 | 10 | 16.4 |
| Time interval from test date to first dose of treatment | ||||||
| <2 wk | 34 | 47.2 | 7 | 33.3 | 27 | 52.9 |
| 2–4 wk | 13 | 18.1 | 4 | 19.0 | 9 | 17.6 |
| >4 wk | 25 | 34.7 | 10 | 47.6 | 15 | 29.4 |
| Adherence to 3 weekly doses§ | ||||||
| Yes | 26 | 36.1 | 10 | 47.6 | 16 | 31.4 |
| No | 20 | 27.8 | 4 | 19.0 | 16 | 31.4 |
| Not documented | 26 | 36.1 | 7 | 33.3 | 19 | 37.2 |
*
Calculation excludes previously tested women, n = 24 (1.0% overall).
†
Based on RPR seroreactivity.
‡
Assumes adherence if sdNVP treatment occurred at labor or during ANC.
§
National guidelines recommend 3 weekly doses of intramuscular benzathine penicillin.